Switch to:
More From Other Websites
Does Luxottica Now Have A Monopoly On The Eyeglass Space? Jan 17 2017
‘Boring’ stocks get more exciting as Trump rally fades Jan 17 2017
Why Bristol-Myers Squibb May Be a Merger Target Soon Jan 17 2017
The Word on the Street: What Analysts Are Recommending for JNJ Jan 16 2017
[$$] Dividend-Hike Heroes Jan 14 2017
Behind Johnson & Johnson’s Recent Stock Performance Jan 13 2017
Here's Why Johnson & Johnson Shares Are Poised for a Rally Jan 13 2017
Could Johnson & Johnson Rip Higher by 20%? Jan 13 2017
Inside Johnson & Johnson’s Latest Dividend Payment Jan 13 2017
Understanding Johnson & Johnson’s Medical Device Business Lawsuit Troubles Jan 13 2017
Pharma company executives debate drug pricing increases Jan 12 2017
Mylan CEO Heather Bresch says caps on drug price increases won’t work Jan 12 2017
Johnson & Johnson’s Expandable Cage Acquisition to Accelerate the Spine Division Jan 12 2017
Johnson & Johnson’s Diabetes Launch to Accelerate the Medical Device Business Jan 12 2017
Johnson & Johnson breached its 50 day moving average in a Bearish Manner : JNJ-US : January 12, 2017 Jan 12 2017
Early movers: AAPL, DAL, DIS, AMZN, GS, JNJ, BA, TM & more Jan 12 2017
Orthocell Announces Collaboration with Johnson & Johnson Innovation Jan 11 2017
US STOCKS-Wall Street ends choppy session higher, health lags on Trump comments Jan 11 2017
Correction: Drug Prices-Johnson & Johnson story Jan 11 2017
Business Highlights Jan 10 2017
Japan's Takeda ready for fresh acquisitions after $5.2 billion Ariad deal Jan 10 2017
J&J, Actelion approach Swiss takeover board over deal structure - paper Jan 06 2017
J&J, Actelion approach Swiss takeover board over deal structure - paper Jan 06 2017
J&J, Actelion approach Swiss takeover board over deal structure - paper Jan 06 2017
Judge halves $1 billion award in J&J hip implants case Jan 04 2017
Johnson & Johnson Announces Quarterly Dividend for First Quarter 2017 Jan 03 2017
EXCLUSIVE: J&J discussing breaking up Actelion in an acquisition - sources Dec 29 2016
EXCLUSIVE: J&J discussing breaking up Actelion in an acquisition - sources Dec 29 2016
Exclusive - J&J discussing breaking up Actelion in an acquisition: sources Dec 29 2016
Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter/Full-Year 2016 Results Dec 27 2016
Monte Paschi shares sink further, bucking steady European trend Dec 22 2016
Actelion re-enters talks with J&J, sidelining Sanofi Dec 22 2016
European shares dip but Italy outperforms despite Monte Paschi volatility Dec 22 2016
European shares pull back, Actelion hits record high Dec 22 2016
MORNING BID EUROPE-Berlin attack - the familiar story unfolds Dec 22 2016
Actelion re-enters talks with J&J, sidelining Sanofi Dec 22 2016
Actelion re-enters talks with J&J, sidelining Sanofi Dec 22 2016
Actelion re-enters talks with J&J, sidelining Sanofi Dec 21 2016
Johnson & Johnson Confirms Exclusive Negotiations with Actelion Dec 21 2016
Actelion and Johnson & Johnson enter into exclusive discussions Dec 21 2016
US stocks edging higher ahead of Yellen speech Dec 19 2016
Actelion talking to Sanofi after J&J exit Dec 14 2016
Actelion talking to Sanofi after J&J exit Dec 14 2016
European shares retreat from 11-month high, Actelion and Colruyt fall Dec 14 2016
Actelion talking to Sanofi after J&J exit Dec 14 2016
European shares retreat from 11-month high, Actelion and Colruyt fall Dec 14 2016
Johnson & Johnson ends talks to buy Actelion Dec 13 2016
Analysis: J&J questions fairness of hip implant trial, $1 bln verdict Dec 07 2016
Analysis: J&J questions fairness of hip implant trial, $1 bln verdict Dec 07 2016
Sanofi exploring bid for Actelion amid J&J talks - Bloomberg Dec 05 2016
Sanofi exploring bid for Actelion amid J&J talks - Bloomberg Dec 05 2016
Actelion's silence has hedge funds betting big on J&J deal Dec 02 2016
Johnson & Johnson hit with over $1 billion verdict on hip implants Dec 01 2016
Johnson & Johnson hit with over $1 billion verdict on hip implants Dec 01 2016
Johnson & Johnson hit with over $1 billion verdict on hip implants Dec 01 2016
Johnson & Johnson hit with over $1 billion verdict on hip implants Dec 01 2016
Actelion's ambitious independent-minded CEO will drive up takeover price Nov 28 2016
US stocks end week at fresh records Nov 25 2016
Actelion shares jump on Johnson & Johnson interest Nov 25 2016
European shares head for 3rd week of gains, Actelion leads Nov 25 2016
BUZZ-AstraZeneca: boosted by Liberum upgrade as Healthcare rallies Nov 25 2016
European shares edge lower but head for 3rd week of gains Nov 25 2016
Actelion shares jump on Johnson & Johnson interest Nov 25 2016
Costly leukaemia pill wins UK green light after price cut Nov 24 2016
Dow closes above 19,000 for the first time Nov 22 2016
Johnson & Johnson Reports 2016 Third-Quarter Results: Nov 14 2016
J&J arthritis drug goes up against Humira, with mixed results Nov 12 2016
J&J; wants cases heard in another court Nov 07 2016
After $195 million in talc verdicts, J&J strives to change court Nov 07 2016
Rio dismissed from US talc lawsuits Oct 30 2016
Rio dismissed from US talc use lawsuits Oct 30 2016
$US70ml awarded in baby powder lawsuit Oct 28 2016
Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2016 Oct 20 2016
Netflix boosts tech shares as US stocks rise Oct 18 2016
Wall Street climbs on earnings improvement Oct 18 2016
US STOCKS-Wall St climbs on earnings improvement Oct 18 2016
US STOCKS-Wall St rallies on earnings optimism Oct 18 2016
J&J warns diabetic patients - Insulin pump vulnerable to hacking Oct 04 2016
Johnson & Johnson Advances Commitment to Improve Global Health and Well-Being Sep 20 2016
Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results Sep 20 2016
Johnson & Johnson Announces Agreement to Acquire Abbott Medical Optics Sep 16 2016
Abbott to Sell Abbott Medical Optics to Johnson & Johnson for $4.325 Billion Sep 16 2016
Johnson & Johnson Announces World Health Organization will Review Ebola Vaccine Regimen for... Sep 12 2016
Johnson & Johnson Partners with Global Citizen to Improve the Trajectory of Human Health Around the... Sep 07 2016
Johnson & Johnson Announces Ruling Related to REMICADE® in the District of Massachusetts Federal... Aug 17 2016
Johnson & Johnson Medical Devices Companies Value-Based Solutions Help Health Systems Address... Aug 04 2016
Weak China sales drag down Smith & Nephew profits Jul 28 2016
J&J to stand behind talc’s safety at upcoming trials - lawyer May 17 2016
Johnson & Johnson ordered to pay $55 million in talc-powder trial May 02 2016
Johnson & Johnson ordered to pay $55 million in talc-powder trial May 02 2016
J&J shares hit new high on strong drug sales, weaker dollar Apr 19 2016
Johnson & Johnson hit with $500 million verdict in hip implant trial Mar 17 2016
FBI probing what J&J knew about uterine surgery device - WSJ May 27 2015
Interview - New-look GSK bets on consumer health spending May 06 2015
J&J cuts full-year forecast due to strong dollar Apr 14 2015
Johnson & Johnson buys energy drink brand in India Nov 07 2014


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK